Combined castration and fractionated radiotherapy in an experimental prostatic adenocarcinoma
- 1 December 1997
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 39 (5) , 1031-1036
- https://doi.org/10.1016/s0360-3016(97)00559-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Clinical and Biochemical Evidence of Control of Prostate Cancer at 5 Years After External Beam RadiationJournal of Urology, 1995
- Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology groupUrology, 1995
- Estramustine potentiates the effects of irradiation on the dunning (R3327) rat prostatic adenocarcinomaThe Prostate, 1994
- Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Hormonal Cytoreduction and Radiotherapy for Carcinoma of the ProstateBritish Journal of Urology, 1992
- Evidence for a non-estrogenic cytostatic effect of estramustine on human prostatic carcinoma cells in vivoThe Prostate, 1992
- Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the dunning R3327 rat prostatic adenocarcinomaThe Prostate, 1989
- Improved control of bulky prostate carcinoma with sequential estrogen and radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Vascular Endothelium as the Vulnerable Element in TumoursActa Radiologica: Oncology, 1984
- Investigation of different combinations of estrogen therapy and radiation therapy on prostatic adenocarcinoma (R-3327)Urology, 1980